(Q37287162)

19 August 2017

1 reference

title

How tumours escape mass destruction (English)

1 reference

19 August 2017

T J Stewart

1

1 reference

PubMed ID

18836470

19 August 2017

S I Abrams

series ordinal

2

1 reference

PubMed ID

18836470

19 August 2017

language of work or name

English

0 references

publication date

1 October 2008

1 reference

19 August 2017

1 reference

19 August 2017

27

1 reference

19 August 2017

5894-5903

1 reference

19 August 2017

45

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2008.268

19 August 2017

0 references

cites work

Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Regulation of immune responses by L-arginine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Immune selective pressure and HLA class I antigen defects in malignant lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Tregs and rethinking cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Adoptive-cell-transfer therapy for the treatment of patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Interferons, immunity and cancer immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Overexpression of Bcl-xL in human breast cancer cells enhances organ-selective lymph node metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Immune escape associated with functional defects in antigen-processing machinery in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

The new B7s: playing a pivotal role in tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Regulation of tumour immunity by CD25+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Fas expression in lung metastasis from osteosarcoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Host immunosurveillance controls tumor growth via IFN regulatory factor-8 dependent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Dendritic cells issued in vitro from bone marrow produce PGE(2) that contributes to the immunomodulation induced by antigen-presenting cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

The role of Fas ligand and transforming growth factor beta in tumor progression: molecular mechanisms of immune privilege via Fas-mediated apoptosis and potential targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Defective proximal TCR signaling inhibits CD8+ tumor-infiltrating lymphocyte lytic function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Checkpoint blockade in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Role of immature myeloid cells in mechanisms of immune evasion in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

PD-L2 is a second ligand for PD-1 and inhibits T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Enhancement of antitumor immunity by CTLA-4 blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Transforming growth factor-beta regulation of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Tumor-associated macrophages press the angiogenic switch in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

IL-2 immunotoxin denileukin diftitox reduces regulatory T cells and enhances vaccine-mediated T-cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Alterations in Fas expression are characteristic of, but not solely responsible for, enhanced metastatic competence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Immune selection and emergence of aggressive tumor variants as negative consequences of Fas-mediated cytotoxicity and altered IFN-gamma-regulated gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

CTL adoptive immunotherapy concurrently mediates tumor regression and tumor escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Exposure of Human Primary Colon Carcinoma Cells to Anti-Fas Interactions Influences the Emergence of Pre-existing Fas-Resistant Metastatic Subpopulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Role of antigen-processing machinery in the in vitro resistance of squamous cell carcinoma of the head and neck cells to recognition by CTL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Immune surveillance against a solid tumor fails because of immunological ignorance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Does the immune system see tumors as foreign or self?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Is human immunosenescence clinically relevant? Looking for ‘immunological risk phenotypes’

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Tumour-educated macrophages promote tumour progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

A phase I trial to determine the optimal biological dose of celecoxib when combined with erlotinib in advanced non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Immune signatures of murine and human cancers reveal unique mechanisms of tumor escape and new targets for cancer immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Regulatory T cells in autoimmmunity*.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

B7-H4, a molecule of the B7 family, negatively regulates T cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Tolerogenic dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Immunological responses can have both pro- and antitumour effects: implications for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Host perforin reduces tumor number but does not increase survival in oncogene-driven mammary adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accomp

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Cancer genes and the pathways they control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Repression of IFN regulatory factor 8 by DNA methylation is a molecular determinant of apoptotic resistance and metastatic phenotype in metastatic tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Tumor immune escape mediated by indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Human CD8+ T cell blasts are more sensitive than CD4+ T cell blasts to regulation by APO2L/TRAIL

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Histological expression of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) in human primary melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Identification of a New Subset of Myeloid Suppressor Cells in Peripheral Blood of Melanoma Patients With Modulation by a Granulocyte-Macrophage Colony-Stimulation Factor–Based Antitumor Vaccine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Vascular endothelial growth factor-trap overcomes defects in dendritic cell differentiation but does not improve antigen-specific immune responses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

CD95(APO-1/Fas)-mediated apoptosis in normal and malignant liver, colon, and hematopoietic cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Coordinate regulation of IFN consensus sequence-binding protein and caspase-1 in the sensitization of human colon carcinoma cells to Fas-mediated apoptosis by IFN-gamma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Split anergy in a CD8+ T cell: receptor-dependent cytolysis in the absence of interleukin-2 production

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Posttransplant malignancies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Inflammation and necrosis promote tumour growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

Myeloid-derived suppressor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.268

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/ONC.2008.268

1 reference

19 August 2017

1 reference

PubMed ID

18836470